XML 31 R20.htm IDEA: XBRL DOCUMENT v3.25.0.1
Business Segments
6 Months Ended
Dec. 31, 2024
Business Segments  
Business Segments

12.  Business Segments

We evaluate performance and allocate resources, based on the Animal Health, Mineral Nutrition and Performance Products segments. Certain of our costs and assets are not directly attributable to a segment or segments and we refer to these items as Corporate. We do not allocate Corporate costs or assets to the other segments because they are not used to evaluate the segments’ operating results or financial position. Corporate costs include certain costs related to executive management, information technology, legal, finance, human resources and business development. The accounting policies of our segments are the same as those described in the summary of significant accounting policies included herein.

We evaluate performance of our segments based on Adjusted EBITDA. We calculate Adjusted EBITDA as net income (loss) plus (a) interest expense, net, (b) provision for income taxes or less benefit for income taxes, (c) depreciation and amortization, (d) other expense or less other income as separately reported on our consolidated statements of operations, including foreign currency (gains) losses, net and (e) certain items that we consider to be unusual, non-operational or non-recurring.

    

Three Months

    

Six Months

For the Periods Ended December 31

    

2024

    

2023

    

2024

    

2023

Net sales

 

 

 

 

 

 

 

 

 

 

 

 

Animal Health

$

229,418

$

173,104

$

411,941

$

333,634

Mineral Nutrition

 

63,250

 

61,347

 

122,312

 

117,373

Performance Products

 

16,593

 

15,492

 

35,440

 

30,285

Total segments

$

309,261

$

249,943

$

569,693

$

481,292

Depreciation and amortization

Animal Health

$

10,286

$

7,348

$

17,949

$

14,697

Mineral Nutrition

 

515

 

660

 

1,031

 

1,306

Performance Products

 

292

 

433

 

625

 

859

Total segments

$

11,093

$

8,441

$

19,605

$

16,862

Adjusted EBITDA

Animal Health

$

58,177

$

39,299

$

98,561

$

67,793

Mineral Nutrition

 

5,702

 

3,507

 

9,464

 

6,388

Performance Products

 

1,888

 

817

 

4,177

 

2,226

Total segments

$

65,767

$

43,623

$

112,202

$

76,407

Reconciliation of income before income taxes to Adjusted EBITDA

Income (loss) before income taxes

$

4,838

$

3,565

$

14,458

$

(8,414)

Interest expense, net

 

8,996

 

4,659

 

16,637

 

9,223

Depreciation and amortization – Total segments

 

11,093

 

8,441

 

19,605

 

16,862

Depreciation and amortization – Corporate

 

481

 

469

 

973

 

919

Corporate costs

17,592

14,171

33,371

28,304

Acquisition-related cost of goods sold

1,634

310

1,634

310

Acquisition-related other

8,815

12,239

Pension settlement cost

249

10,674

Brazil employment taxes

4,202

4,202

Insurance settlement gain

(1,257)

(1,257)

Stock-based compensation expense

180

80

359

161

Phibro Forward income growth initiatives

1,696

2,046

Foreign currency losses, net

 

11,699

 

7,477

 

12,137

 

14,166

Adjusted EBITDA – Total segments

$

65,767

$

43,623

$

112,202

$

76,407

 

 

 

December 31, 

    

June 30, 

As of

    

2024

    

2024

Identifiable assets

 

  

 

  

Animal Health

$

1,011,145

$

684,407

Mineral Nutrition

 

76,950

 

67,088

Performance Products

 

50,998

 

50,862

Total segments

 

1,139,093

 

802,357

Corporate

 

146,416

 

179,827

Total

$

1,285,509

$

982,184

 

 

The Animal Health segment includes all goodwill of the Company. Corporate assets include cash and cash equivalents, short-term investments, debt issuance costs, income tax-related assets and certain other assets.